3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
4
Motor Activity
3
Prostatic Neoplasms
2
Breast Neoplasms
2
Urologic Neoplasms
1
Testicular Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Rectal Neoplasms
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neuromuscular Diseases
1
Neoplasm Metastasis
1
Myotonic Dystrophy
1
Myositis, Inclusion Body
1
Muscular Dystrophy, Facioscapulohumeral
1
Muscular Dystrophies, Limb-Girdle
1
Muscular Atrophy, Spinal
1
Multiple Myeloma
1
Lymphoma, B-Cell
1
Lymphedema
1
Lung Neoplasms
1
Low Anterior Resection Syndrome
1
Lambert-Eaton Myasthenic Syndrome
1
Kidney Neoplasms
1
Hereditary Sensory and Motor Neuropathy
1
Hematologic Neoplasms
1
Interventions
fludarabine
2
Cyclophosphamide
2
thymoglobulin
1
prednylidene
1
efgartigimod alfa
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Prednisone
1
Physical Therapy Modalities
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Etoposide
1
Cytarabine
1
Carmustine
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
×
Physical Therapy Modalities
×
1 year
×
Clear all
NCT07072676
2025-07-18
Risk of fall
LMU Klinikum
Phase NA
Enrolling by invitation
30 enrolled